Scholarlink

Background <p>Postoperative chylothorax is a serious complication following esophagectomy. The efficacy of thoracic duct ligation (TDL) for chylothorax prevention is controversial. This study aimed to evaluate the impact of TDL on chylothorax prevention, postoperative biochemical changes, and overall survival (OS) in esophageal cancer patients.</p> Methods <p>We conducted a retrospective cohort study including 991 patients who underwent esophagectomy for esophageal cancer(May 2017-May 2020), stratified into TDL (n = 286) and non-TDL (n = 705) groups. Propensity score matching (PSM) was employed to minimize selection bias(<i>252</i> pairs matched). Primary endpoints included chylothorax incidence, postoperative biochemical markers, and 5-year OS.</p> Results <p>TDL did not reduce the incidence of chylothorax (1.2% vs. 1.2%, <i>P</i> = 1.000). It significantly decreased serum protein levels (postoperative ALB 31.8 vs. 32.5&#xa0;g/L, P= 0.047), while liver enzymes and bilirubin remained unaffected. No survival benefit was observed (5-year OS 42% vs. 45%, P = 0.49).</p> Conclusion <p>After excluding invasion cases and balancing measurable confounders, TDL was not associated with a lower incidence of chylothorax or improved long-term survival.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Thoracic duct ligation during esophagectomy fails to prevent chylothorax or improve survival: a propensity score matched cohort study

  • 期刊论文

  • 发表日期：

    2026年6月2日

查看全文
  • Siyu Quan,
  • Hounai Xie,
  • Deguo Zhang,
  • Fengqi Guo,
  • Zhichen Li,
  • Yun Li

摘要

Background

Postoperative chylothorax is a serious complication following esophagectomy. The efficacy of thoracic duct ligation (TDL) for chylothorax prevention is controversial. This study aimed to evaluate the impact of TDL on chylothorax prevention, postoperative biochemical changes, and overall survival (OS) in esophageal cancer patients.

Methods

We conducted a retrospective cohort study including 991 patients who underwent esophagectomy for esophageal cancer(May 2017-May 2020), stratified into TDL (n = 286) and non-TDL (n = 705) groups. Propensity score matching (PSM) was employed to minimize selection bias(252 pairs matched). Primary endpoints included chylothorax incidence, postoperative biochemical markers, and 5-year OS.

Results

TDL did not reduce the incidence of chylothorax (1.2% vs. 1.2%, P = 1.000). It significantly decreased serum protein levels (postoperative ALB 31.8 vs. 32.5 g/L, P= 0.047), while liver enzymes and bilirubin remained unaffected. No survival benefit was observed (5-year OS 42% vs. 45%, P = 0.49).

Conclusion

After excluding invasion cases and balancing measurable confounders, TDL was not associated with a lower incidence of chylothorax or improved long-term survival.